Movement disorders – including Essential Tremor, Huntington’s Disease, Parkinson’s Disease, Spasticity, and Progressive Supranuclear Palsy (PSP) – demand sophisticated understanding of disease progression, treatment complexity, motor symptom management, patient and caregiver burden. As the therapeutic landscape expands with novel neuroprotective agents, advanced motor therapies, and emerging symptomatic interventions, obtaining high-quality real-world evidence is critical to support clinical strategies, inform healthcare decisions, and demonstrate clinical and quality-of-life value to key stakeholders.
Adelphi Real World’s Disease Specific Programmes (DSPs) are purpose-built to address these challenges.
Our Movement Disorder DSPs provide comprehensive, actionable real-world data and insights tailored to the distinctive features of motor disease progression and symptom management. By engaging directly with movement disorder specialists, neurologists, patients, and caregivers, our DSPs deliver granular perspectives on:
Treatment Sequencing & Management Patterns
Understand real-world therapy selection, combination strategies, and sequential treatment approaches across movement disorder types, disease stages, patient demographics, and healthcare systems – capturing adoption of emerging therapies and treatment decision pathways in routine movement disorder practice.
Physician Decision-Making
Explore the clinical reasoning behind treatment choices, factors influencing therapy selection in early versus more advanced disease states, motor and non-motor symptom management strategies, and approaches to condition monitoring and functional assessment.
Patient & Caregiver Experiences & Outcomes
Document real-world efficacy, tolerability profiles, motor symptom control, functional preservation, quality of life, caregiver burden, support needs, and lived experiences in everyday clinical settings – revealing gaps between trial data and real-world patient and family experience across movement disorder populations.
Emerging Unmet Needs
Uncover persistent treatment challenges, gaps in disease management, emerging therapeutic opportunities, motor decline prevention strategies, treatment side effect management, caregiver support barriers, and opportunities for therapeutic innovation and positioning to better serve patients with movement disorders.
Movement Disorder Disease Specific Programmes (DSP) Portfolio
Why Partner With Adelphi Real World for Movement Disorder Research?
Extensive Global Coverage
Our DSP network spans multiple countries, providing robust comparative insights into movement disorder practice, treatment adoption, diagnostic approaches, and healthcare delivery across diverse healthcare systems.
Deep Clinical Expertise
With specialised knowledge of movement disorders, we ensure our data collection, analysis, and interpretation reflect the true complexity of motor disease management and the needs of treating clinicians and supporting caregivers.
Evidence That Drives Impact
From clinical development to reimbursement and healthcare provider engagement, our movement disorder DSPs provide the credible, compelling evidence needed to influence decisions across the healthcare ecosystem.
Movement Disorder DSP Coverage
Who We Work With
We partner strategically with biopharmaceutical innovators, neurology practices, movement disorder specialist centres, hospital networks, functional neurosurgery facilities, rehabilitation centres, patient support organisations, caregiver advocacy groups, and healthcare policymakers to generate evidence that transforms movement disorder care globally.
Let’s Get Started
-
Schedule a Consultation: Meet with our movement disorder specialists to discuss how our DSPs can support your research, development, and market access objectives across Essential Tremor, Huntington Disease, Parkinson Disease, and PSP.
-
Get More Details: Want to explore our methodology, disease focus areas, global reach, caregiver insights, or specialist networks? We’re here to answer your questions and provide customised information.
Adelphi Real World brings together real-world expertise, movement disorder insight, and global reach to help you succeed in movement disorder research. Let’s collaborate to advance evidence and improve outcomes for patients with movement disorders.
Contact us today using the form below.
Conferences Attending
Observational Research